Hudock, Inc. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hudock, Inc. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$48,000
+92.0%
2240.0%0.02%
+87.5%
Q4 2020$25,000
+19.0%
2240.0%0.01%0.0%
Q3 2020$21,000
-22.2%
2240.0%0.01%
-20.0%
Q2 2020$27,000
+42.1%
2240.0%0.01%
+42.9%
Q1 2020$19,000
-17.4%
2240.0%0.01%
-12.5%
Q4 2019$23,000
+15.0%
224
+28.7%
0.01%
+14.3%
Q3 2019$20,000
+66.7%
174
+148.6%
0.01%
+75.0%
Q2 2019$12,000
+9.1%
700.0%0.00%0.0%
Q1 2019$11,000
-8.3%
70
-53.3%
0.00%
-42.9%
Q3 2014$12,000
-7.7%
150
+25.0%
0.01%
-53.3%
Q2 2014$13,0001200.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders